메뉴 건너뛰기




Volumn 40, Issue 1, 2014, Pages 82-84

Probable linagliptin-induced liver toxicity: A case report

Author keywords

DPP 4 inhibitors; Drug induced liver toxicity; Linagliptin

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; LINAGLIPTIN; LIVER ENZYME;

EID: 84893806596     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2013.09.009     Document Type: Article
Times cited : (17)

References (14)
  • 2
    • 82855179439 scopus 로고    scopus 로고
    • Tolerability of dipeptidyl peptidase-4 inhibitors: a review
    • Richard K.R., Shelburne J.S., Kirk J.K. Tolerability of dipeptidyl peptidase-4 inhibitors: a review. Clin Ther 2011, 33:1609-1629.
    • (2011) Clin Ther , vol.33 , pp. 1609-1629
    • Richard, K.R.1    Shelburne, J.S.2    Kirk, J.K.3
  • 3
    • 83455210130 scopus 로고    scopus 로고
    • Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetes
    • Forst T., Pfützner A. Linagliptin, a dipeptidyl peptidase-4 inhibitor with a unique pharmacological profile, and efficacy in a broad range of patients with type 2 diabetes. Expert Opin Pharmacother 2012, 13:101-110.
    • (2012) Expert Opin Pharmacother , vol.13 , pp. 101-110
    • Forst, T.1    Pfützner, A.2
  • 4
    • 84858011452 scopus 로고    scopus 로고
    • Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus
    • Neumiller J.J. Pharmacology, efficacy, and safety of linagliptin for the treatment of type 2 diabetes mellitus. Ann Pharmacother 2012, 46:358-367.
    • (2012) Ann Pharmacother , vol.46 , pp. 358-367
    • Neumiller, J.J.1
  • 5
    • 84857917241 scopus 로고    scopus 로고
    • Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux
    • Fuchs H., Runge F., Held H.D. Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux. Eur J Pharm Sci 2012, 45:533-538.
    • (2012) Eur J Pharm Sci , vol.45 , pp. 533-538
    • Fuchs, H.1    Runge, F.2    Held, H.D.3
  • 7
    • 84893745980 scopus 로고    scopus 로고
    • Package insert with linagliptin drug information.
    • Package insert with linagliptin drug information. http://www.info.pmda.go.jp/go/pack/3969014F1024_1_05.
  • 10
    • 0027448634 scopus 로고
    • Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge
    • Benichou C., Danan G., Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993, 46:1331-1336.
    • (1993) J Clin Epidemiol , vol.46 , pp. 1331-1336
    • Benichou, C.1    Danan, G.2    Flahault, A.3
  • 11
    • 84876523499 scopus 로고    scopus 로고
    • Dipeptidyl peptidase-4: a key player in chronic liver disease
    • Itou M., Kawaguchi T., Taniguchi E., Sata M. Dipeptidyl peptidase-4: a key player in chronic liver disease. World J Gastroenterol 2013, 19:2298-2306.
    • (2013) World J Gastroenterol , vol.19 , pp. 2298-2306
    • Itou, M.1    Kawaguchi, T.2    Taniguchi, E.3    Sata, M.4
  • 12
    • 75449112589 scopus 로고    scopus 로고
    • Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
    • Lammert C., Bjornsson E., Niklasson A., Chalasani N. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 2010, 51:615-620.
    • (2010) Hepatology , vol.51 , pp. 615-620
    • Lammert, C.1    Bjornsson, E.2    Niklasson, A.3    Chalasani, N.4
  • 13
    • 76149095920 scopus 로고    scopus 로고
    • Elevated hepatic enzymes potentially associated with sitagliptin
    • Gross B.N., Cross L.B., Foard J., Wood Y. Elevated hepatic enzymes potentially associated with sitagliptin. Ann Pharmacother 2010, 44:394-395.
    • (2010) Ann Pharmacother , vol.44 , pp. 394-395
    • Gross, B.N.1    Cross, L.B.2    Foard, J.3    Wood, Y.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.